ACUTE LYMPHOCYTIC LEUKEMIA OPTIONS

Article-remission therapy: This is actually the second period of treatment. It commences once the leukemia is in remission.The FDA authorised in 2021 rilpivirine IM and cabotegravir IM as a whole after month to month regimen for treatment of HIV-1 infection in Older people to exchange a present steady ART regimen in those people who are virological